Clinical Trial Update: Clinical Trial With Clobetasol and Dexamethasone for Topical Treatment of Oral Lesions of Chronic Graft-versus-host Disease [Phase 3]

View source ↗

Summary

Phase 3 completed clinical trial evaluating topical clobetasol and dexamethasone for oral lesions in chronic graft-versus-host disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Clobetasol (clobetasol)
• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Grupo de Estudos Multicentricos em Onco-Hematologia | Conditions: Graft vs Host Disease, Oral Manifestations | Phase 3 | Status: COMPLETED